Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Japan.
Department of Clinical Immunology, Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris (APHP), France.
Intern Med. 2024 Apr 1;63(7):993-998. doi: 10.2169/internalmedicine.2284-23. Epub 2023 Aug 9.
Hodgkin lymphoma (HL) and idiopathic multicentric Castleman disease (iMCD) are markedly different conditions. However, in some cases, histological similarities caused by elevated cytokines, including interleukin-6, can lead to a misdiagnosis of HL as Castleman disease (CD). We herein report a patient with HL who had been diagnosed with CD by an expert panel and for whom an additional biopsy was useful for determining the correct diagnosis. Furthermore, we analyzed the positron emission tomography/computed tomography findings at the diagnosis and found that the maximum standardized uptake value was useful for distinguishing HL from iMCD.
霍奇金淋巴瘤(HL)和特发性多中心 Castleman 病(iMCD)是明显不同的疾病。然而,在某些情况下,升高的细胞因子(包括白细胞介素-6)引起的组织学相似性可能导致 HL 误诊为 Castleman 病(CD)。本文报告了一例 HL 患者,曾被专家组诊断为 CD,再次进行活检有助于确定正确的诊断。此外,我们分析了诊断时的正电子发射断层扫描/计算机断层扫描结果,发现最大标准化摄取值有助于区分 HL 和 iMCD。